SESN2 and metabolic dysfunction-associated steatotic liver disease: In liver diseases such as non-alcoholic fatty liver disease (NAFLD), SESN2 (fly Sesn) slows disease progression by balancing glycolipid metabolism through macroautophagy (lipophagy) and delays the onset and progression of fibrogenesis (Lu et al., 2023).